Smith-Lemli-Opitz Syndrome
Oncology·MeSH: Smith-Lemli-Opitz Syndrome
Prevalence
5.0 / 100K
0 drugs in development·0 companies·2 clinical trials
Frequently asked questions
How many clinical trials target Smith-Lemli-Opitz Syndrome?
There are 2 clinical trials targeting Smith-Lemli-Opitz Syndrome tracked by BioSniper.
What is the prevalence of Smith-Lemli-Opitz Syndrome?
The estimated prevalence of Smith-Lemli-Opitz Syndrome is approximately 5.0 per 100,000 population.
Deep-dive into Smith-Lemli-Opitz Syndrome
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis